Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almeda Ventures LPXTAE:AMDA -5.54%10 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates XTAE:AMDA with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 670 Healthcare Providers & Services companies, Almeda Ventures LP ranks worse than 149253.58% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Almeda Ventures LP EBITDA Margin % Related Terms
Almeda Ventures LP EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Almeda Ventures LP's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almeda Ventures LP EBITDA Margin % Chart
Almeda Ventures LP Annual Data
Trend
EBITDA Margin %
Almeda Ventures LP Semi-Annual Data
EBITDA Margin %
XTAE:AMDA vs VEEV, BTSG, HQY: EBITDA Margin % Comparison
For the Health Information Services subindustry, Almeda Ventures LP's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almeda Ventures LP EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almeda Ventures LP's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Almeda Ventures LP's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almeda Ventures LP (XTAE:AMDA) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Almeda Ventures LP and its competitors. According to the industry distribution chart, Almeda Ventures LP ranks #999999 out of 670 companies in the Healthcare Providers & Services industry.
Is Almeda Ventures LP's EBITDA Margin % too high?
Almeda Ventures LP's current EBITDA Margin % is 0.00%. Based on the distribution chart, Almeda Ventures LP ranks #999999 out of 670 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Almeda Ventures LP has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Almeda Ventures LP's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Almeda Ventures LP ranks #999999 out of 670 companies for EBITDA Margin %. This places Almeda Ventures LP in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Almeda Ventures LP and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almeda Ventures LP's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almeda Ventures LP stock overvalued right now?
Almeda Ventures LP (XTAE:AMDA) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Almeda Ventures LP's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Almeda Ventures LP (XTAE:AMDA), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almeda Ventures LP is a life science research and development company. The company invests in Medical devices and Digital health businesses. Its portfolio includes BioProtect, which developed a proprietary technology platform for biodegradable balloons. The technology suits a range of clinical applications, including spacing for radiation oncology protection and general surgery. TailorMed technology improves the financial performance of healthcare providers and reduces financial hardship for patients.
10GF Score
Get the complete analysis for XTAE:AMDA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:AMDA has been successfully added to your 
